 |
8 Diseases |  |
0 Trials |
|
0 Trials |  |
25 News |  |
- | Evorel (estradiol transdermal) / J&J
Journal: Navigating the microbial community in the trachea-oropharynx of breast cancer patients with or without neoadjuvant chemotherapy (NAC) via endotracheal tube: has NAC caused any change? (Pubmed Central) - Dec 3, 2023
Here, we provide the first comparison data of the respiratory tract microbiome of breast cancer patients with or without NAC via NGS analysis. This study ultimately seeks to contribute to future studies on the lower respiratory tract in cancer patients with cytotoxic chemotherapy by establishing reliable control data.
- || Evorel (estradiol transdermal) / J&J
https://t.co/myEzKQcUDu #iwishicouldbeplayingwithhishairrightnow @Shimha18 @GuerillaSA @KeckMedUSC @KECKSchool_USC @USCneurorads @USC_Rads @RadiologyUSC @USCRadResearch @USC_ERad @ashishkjha @iko_uwais @vince_uy @trevorellestad (Twitter) - Nov 20, 2022
- | Evorel (estradiol transdermal) / J&J
Journal: Variability of response to early puberty induction demonstrated by transverse uterine diameter measurement and a novel method of 3D breast imaging. (Pubmed Central) - Jun 22, 2022
In the absence of sensitive oestradiol assays, uterine transverse measurements may be used as a surrogate marker of oestrogen sensitivity to guide early dose adjustment. 3D breast imaging may provide a quantitative assessment of breast development to complement Tanner breast staging.
- | Utrogestan (progesterone) / Besins Healthcare
Biomarker, Journal, Combination therapy: Impact of micronised progesterone and medroxyprogesterone acetate in combination with transdermal oestradiol on cardiovascular markers in women diagnosed with premature ovarian insufficiency or an early menopause: a randomised pilot trial. (Pubmed Central) - Jun 19, 2022
3D breast imaging may provide a quantitative assessment of breast development to complement Tanner breast staging. The positive changes in traditional markers were not reflected in the cardiogenic biomarker, cfPWV, which has demonstrated a higher positive predictive value for cardiovascular events than traditional measurements.
- ||| Evorel (estradiol transdermal) / J&J
I’m on the Evorel patches too. Have been since August 2020 a month before my diagnosis of PPMS 😭. Unfortunately HRT hasn’t helped with the insomnia, so I’m beginning to think is it the MS? If so what can work. Feel like a zombie most days 🤦🏼♀️ (Twitter) - Jan 10, 2022
- | Evorel (estradiol transdermal) / J&J
@JNJNews EN DONDE PODRÍA CONSEGUIR EL HORMONAL EVOREL 25 EN MEXICO? (Twitter) - Mar 18, 2021
- ||| Evorel (estradiol transdermal) / J&J
Adverse events, Gold Standard: Evorel patches contain synthetic progesterone which is not the gold standard. I would always recommend body-identical Uterogestan, which has the best risk profile, including breast cancer, and rarely causes any progestogenic side effects - unlike synthetics. 👍 (Twitter) - Apr 15, 2019
- | Evorel (estradiol transdermal) / J&J
New P4 trial: OPTIMISE: Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Therapy (clinicaltrials.gov) - Oct 17, 2014
P4, N=60, Recruiting, Sponsor: Royal Brompton & Harefield NHS Foundation Trust